Molecular nuclear imaging: The radiopharmaceuticals (Review)

被引:33
作者
Imam, SK [1 ]
机构
[1] Liverpool Hosp, Dept Nucl Med, Sydney, NSW 2170, Australia
关键词
molecular imaging; radiopharmaceuticals; FDG; FLT; annexin;
D O I
10.1089/cbr.2005.20.163
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Application of the nuclear approach for the detection of inherited diseases is an important goal for nuclear medicine and will likely result in an important breakthrough, which will, hopefully, lead to improved diagnoses of genetic defects and objective evaluations of the efficacy of therapeutic strategies. Although still largely in the research realm, molecular imaging is in the process of emerging as a vital component of the diagnosis of disease and monitoring of the therapy. The clinical research in nuclear medicine has made major advancements in the direction of molecular medicine and targeted therapy. In the past few years, exponential achievements have been accomplished in the development of molecular nuclear imaging agents, as described below.
引用
收藏
页码:163 / 172
页数:10
相关论文
共 51 条
[31]   Prospective investigation of positron emission tomography in lung nodules [J].
Lowe, VJ ;
Fletcher, JW ;
Gobar, L ;
Lawson, M ;
Kirchner, P ;
Valk, P ;
Karis, J ;
Hubner, K ;
Delbeke, D ;
Heiberg, EV ;
Patz, EF ;
Coleman, RE .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :1075-1084
[32]   Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide [J].
Menda, Y ;
Kahn, D .
SEMINARS IN NUCLEAR MEDICINE, 2002, 32 (02) :92-96
[33]  
MOADEL RM, 2003, BREAST CANCER RES, V5, P329
[34]  
Mochizuki T, 2003, J NUCL MED, V44, P92
[35]  
Pan Ding-Yu, 2003, Hepatobiliary Pancreat Dis Int, V2, P211
[36]   Octreotide for palliative treatment of hepatic metastases from non-neuroendocrine primary tumours: evaluation of quality of life using the EORTC QLQ-C30 questionnaire [J].
Pistevou-Gombaki, K ;
Eleftheriadis, N ;
Plataniotis, GA ;
Sofroniadis, I ;
Kouloulias, VE .
PALLIATIVE MEDICINE, 2003, 17 (03) :257-262
[37]   111In-capromab pendetide -: The evolution of prostate specific membrane antigen and the nuclear imaging of its 111In-labelled murine antibody in the evaluation of prostate cancer [J].
Plut, EM ;
Hinkle, GH .
BIODRUGS, 2000, 13 (06) :437-447
[38]   Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy [J].
Raj, GV ;
Partin, AW ;
Polascik, TJ .
CANCER, 2002, 94 (04) :987-996
[39]  
ROLLO FD, 2003, MEDICAMUNDI, V14, P10
[40]  
Slooter GD, 2002, J NUCL MED, V43, P1681